Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Covid-19 Symptom Severity Myeloma
Covid-19 Symptom Severity Myeloma
Covid-19 symptom severity is worse in myeloma survivors according to the study linked below. I should specify that the study focuses on cancer survivors in general. I am specifically talking about MM survivors.
Numerous studies confirm that MM survivors have compromised immune systems both as a result of toxic therapies as well as due to myeloma itself. MM survivors are more susceptible to the covid-19 virus. The study below focuses on covid-19 symptoms.
According to the study, because cancer survivors, on average, are vaccinated against covid-19, they have the same risk of long-covid as average people do.
Because covid-19 vaccination is controversial, the study is saying that while MM patients may experience more severe symptoms if they catch covid-19, they have an average risk of long-covid systems because a higher percentage of MM survivors have been vaccinated against the covid virus.
I am a myeloma survivor. I got covid-19 once before. I can’t prove it but I believe that my symptoms were average based on the fact that I was vaccinated for the covid-19 disease.
Do you have MM? Covid too? Email me at David.PeopleBeatingCancer@gmail.com with your questions about covid and MM.
Thank you,
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
COVID-19 Symptom Severity Increased in Cancer Survivors
Adult cancer survivors in the United States were more likely to report severe COVID-19 symptoms compared to the general population, based on data from a new study of nearly 9000 individuals presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 Annual Meeting.
“COVID-19 can have many long-lasting adverse effects on individuals’ health outcomes and wellbeing,” said Jincong (Jason) Freeman, PhD, of the University of Chicago, Chicago, in an interview. The population of cancer survivors in the United States is both aging and growing, and studies have shown that this population may be more vulnerable to COVID-19, but data on symptoms, vaccination, and long COVID in cancer survivors are lacking, Freeman said…
The researchers reviewed data on symptom severity and COVID-19 vaccination status.
- Significantly more cancer survivors had severe COVID-19 symptoms compared to the general population (17.9% vs 14.3%, P = .019).
- In addition, significantly more cancer survivors received a COVID-19 vaccine compared to the general population (88.6% vs 78.6%, P < .001).
The finding that cancer survivors experienced more severe COVID-19 symptoms than the general population was not unexpected, as the survivor population is older and often experience more chronic health conditions and/or a weakened immune system, Freeman told Medscape Medical News.
However, “To our surprise, cancer survivors had similar odds (still a bit high given an odds ratio of 1.05) of experiencing long COVID to the general population, which contradicts our initial hypothesis that survivors would have significantly greater odds,” he said.
“But we observed that the COVID-19 vaccination rate was higher in cancer survivors (88.6%) than in the general population (78.6%), which likely explains the similar odds of long COVID-19 due to the vaccine’s protective effect for the survivor population,” he noted…
A key takeaway from the study is the need to continue to identify and address COVID-19 symptom severity in cancer survivors, said Freeman. “At the same time, although the COVID-19 vaccination rate is higher in the cancer survivor population, 1 in 9 (1 in 5 of the general population) still did not receive at least one dose of the vaccine,” he noted. The results suggest that clinics and cancer programs should promote COVID-19 vaccination regardless of cancer history while ensuring equitable access to COVID-19 care and services, he added…
Mazumder said that the increased frequency of severe symptoms in cancer survivors was not unexpected, but clinicians should be aware that symptoms of COVID-19 can be more severe in cancer survivors. Consequently, these patients should be monitored closely once diagnosed with COVID-19 to ensure that antiviral treatment is offered if appropriate to potentially reduce the rate of complications, she added.
Covid-19 symptom severity myeloma Covid-19 symptom severity myeloma
Covid-19 symptom severity myeloma